Finance

Beta
Lists
VCYT:NASDAQ
Veracyte Inc
$60.33
+3.04%
(+1.78) 1D
Jun 26, 11:35:05 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VCYT...
Open
$58.55
High
$60.17
Low
$58.06
Mkt. cap
4.78B
Avg. vol.
1.32M
Volume
250.80K
P/E ratio
55.73
52-wk high
$60.28
52-wk low
$22.61
EPS
$1.08
Beta
1.98
Shares outstanding
79.79M
No. of employees
755
Open
$58.55
High
$60.17
Low
$58.06
Mkt. cap
4.78B
Avg. vol.
1.32M
Volume
250.80K
P/E ratio
55.73
52-wk high
$60.28
52-wk low
$22.61
EPS
$1.08
Beta
1.98
Shares outstanding
79.79M
No. of employees
755
News stories
From sources across the web
About Veracyte Inc
CEO-
Employees755
Founded2006
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteveracyte.com
Analyst ratings
Based on 9 analysts giving stock ratings to VCYT in the past 3 months
Buy
Buy
7
Hold
1
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for VCYT in the last 3 months.
Highest
Current $60.33
$57.00 (-5.52%)
Average
$47.57 (-21.15%)
Lowest
$37.00 (-38.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kyle Mikson CFA
Canaccord Genuity
Hold
Reiterated
$42.00
-30.4%
06/02/2026
Paige Chamberlain‏
Wolfe Research
Buy
Reiterated
$55.00
-8.8%
06/01/2026
Unknown Analyst
Wolfe Research
Buy
Reiterated
$55.00
-8.8%
06/01/2026
Michael Matson
Needham
Buy
Reiterated
$57.00
-5.5%
06/01/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/22/2026
Kallum Titchmarsh
Morgan Stanley
Sell
Maintained
$37.00
-38.7%
05/12/2026
Lu Li
UBS
Buy
Maintained
$52.00
-13.8%
05/06/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/06/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$45.00
-25.4%
05/06/2026
Tycho Peterson
Jefferies
Buy
Initiated
$45.00
-25.4%
04/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
130.16M
131.87M
140.64M
139.07M
Cost of goods sold
37.73M
34.80M
45.35M
35.20M
Cost of revenue
37.73M
34.80M
45.35M
35.20M
Research and development expenses
16.26M
15.98M
20.85M
27.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.57M
54.64M
46.49M
50.84M
Operating expense
78.12M
73.96M
70.67M
81.22M
Total operating expenses
115.85M
108.76M
116.02M
116.42M
Operating income
14.31M
23.11M
24.61M
22.65M
Other non operating income
233.00K
1.00K
-15.00K
3.83M
EBT including unusual items
1.25M
18.89M
40.63M
29.97M
EBT excluding unusual items
20.83M
25.76M
28.05M
29.97M
Income tax expense
2.23M
-248.00K
-515.00K
1.27M
Effective tax rate
178.40%
-1.31%
-1.27%
4.23%
Other operating expenses
-
-
-
-
Net income
-980.00K
19.14M
41.15M
28.71M
Net profit margin
-0.75%
14.51%
29.26%
20.64%
Earnings per share
0.44
0.51
0.53
0.52
Interest and investment income
2.94M
3.48M
3.54M
3.48M
Interest expense
-
-
-
-
Net interest expenses
2.94M
3.48M
3.54M
3.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
19.80M
28.38M
29.91M
28.08M
Gain or loss from assets sale
15.00K
3.86M
2.84M
366.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VCYT
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer